Literature DB >> 34913428

COVID-19 booster vaccine willingness.

Kim Mannemar Sønderskov, Helene Tilma Vistisen, Peter Thisted Dinesen, Søren Dinesen Østergaard1.   

Abstract

INTRODUCTION: As the protection from the COVID-19 vaccines diminishes over time, health authorities are currently considering how to maintain immunity by means of vaccine booster doses. In a recent survey, we investigated COVID-19 booster vaccine willingness among Danes, a population with a high acceptance of the initial round of COVID-19 vaccination.
METHODS: The data were derived from the sixth wave of the longitudinal COVID-19 Consequences Denmark Panel Survey 2020, which included questions on booster vaccine willingness. The data from the respondents were primarily analysed using descriptive statistics. The association between age, gender, level of education, region, type of received vaccine and booster vaccine willingness was analysed using multivariate logistic regression.
RESULTS: Among those reporting to be vaccinated against COVID-19 or that their vaccination was scheduled, a weighted total of 90% indicated that they were willing to receive the booster vaccine, if/once offered. The only characteristic associated with booster vaccine willingness at the set level of statistical significance (0.05) was age (increased willingness with age; adjusted odds ratio per year: 1.04, 95% confidence interval: 1.02-1.06).
CONCLUSIONS: The willingness to receive a booster dose of a COVID-19 vaccine is high among Danes. If health authorities decide to offer COVID-19 booster vaccines to the young, they may consider providing specific information targeted at this population to increase uptake. FUNDING: The Novo Nordisk Foundation. TRIAL REGISTRATION: not relevant. Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34913428

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  6 in total

1.  Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.

Authors:  Walid Al-Qerem; Anan Jarab; Alaa Hammad; Alaa Hussein Alsajri; Shadan Waleed Al-Hishma; Jonathan Ling; Asal Saad Alabdullah; Ali Salama; Rami Mosleh
Journal:  Patient Prefer Adherence       Date:  2022-06-23       Impact factor: 2.314

2.  Public support for unequal treatment of unvaccinated citizens: Evidence from Denmark.

Authors:  Julian Schuessler; Peter Thisted Dinesen; Søren Dinesen Østergaard; Kim Mannemar Sønderskov
Journal:  Soc Sci Med       Date:  2022-06-01       Impact factor: 5.379

3.  Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study.

Authors:  Jakob Weitzer; Brenda M Birmann; Ilja Steffelbauer; Martin Bertau; Lukas Zenk; Guido Caniglia; Manfred D Laubichler; Gerald Steiner; Eva S Schernhammer
Journal:  Lancet Reg Health Eur       Date:  2022-05-29

4.  Coverage of Coronavirus Disease-2019 (COVID-19) Booster Dose (Precautionary) in the Adult Population: An Online Survey.

Authors:  Ramesh Masthi Nr; Anagha Brahmajosyula; Aniket Khamar; Namita Acharya; Lavanya P Bilichod; Deepika Kondath
Journal:  Cureus       Date:  2022-07-16

5.  Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia.

Authors:  Maha Farhat; Rabab Al-Ibrahim; Abrar Almohammedali; Roaa Aljishi; Baneen Alalwan
Journal:  Int J Gen Med       Date:  2022-09-28

6.  Willingness to Take the Booster Vaccine in a Nationally Representative Sample of Danes.

Authors:  Frederik Juhl Jørgensen; Louise Halberg Nielsen; Michael Bang Petersen
Journal:  Vaccines (Basel)       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.